This ECCO topical review of the European Crohn’s and Colitis Organisation [ECCO] focuses
on the epidemiology, pathophysiology, diagnosis, management and outcome of the two …

This study presents the results of applying deep learning methodologies within the
ecotoxicology field, with the objective of training predictive models that can support hazard …

Nanotechnology has enabled the discovery of a multitude of novel materials exhibiting unique
physicochemical (PChem) properties compared to their bulk analogues. These properties …

Engineered nanomaterials (ENMs) enable new and enhanced products and devices in which
matter can be controlled at a near-atomic scale (in the range of 1 to 100 nm). However, the …

Background and Aims: Extraintestinal manifestations [EIMs] are common in inflammatory
bowel disease [IBD]. Data on epidemiology and risk factors of EIMs in IBD patients are limited. …

Background and Aims This study aimed to compare real-world clinical effectiveness and
safety of vedolizumab, an α4β7-integrin inhibitor, and anti-tumour necrosis factor-α [anti-TNFα] …

The contribution of epigenetic alterations to disease pathogenesis is emerging as a
research priority. In this study, we aimed to seek DNA methylation changes in peripheral …

The cause of inflammatory bowel disease, encompassing Crohn’s disease and ulcerative
colitis, remains a mystery but evidence is accumulating that complex interactions between the …

Introduction and Aims As inflammatory bowel diseases [IBD] affect female patients almost
exclusively during their reproductive age, issues related to fertility, fecundity, pregnancy, …

Background & Aims Infliximab is a safe and effective therapy for ulcerative colitis (UC). We
conducted a multicenter retrospective cohort study that included 7 European countries and …